StockData
Dolby Laboratories, Inc. logo

Dolby Laboratories, Inc. (DLB) stock

DLBNYSEPatent Owners & LessorsFiscal year ends September 27
Financials through Q4 FY2026, quarter ended Sep 25, 2026Last filing: 10-K on Nov 17, 2026Score 21/3017% below fair value
$56.77−2.05 (-3.49%)

Close on Nov 18, 2026Market cap $5.32BP/E 21.0Yield 2.54%

Dolby Laboratories free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Dolby Laboratories's free cash flow for the twelve months ending Sep 25, 2026 was $359.91M, down 17.4% year over year. For fiscal 2026 it was $359.91M, down 17.4% from the year before. Over ten years it grew 3.3% a year on average. The highest annual figure on record is $435.85M in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Sep 25, 2026$359.91M-17.4%
FY2025Sep 26, 2025$435.85M+46.6%
FY2024Sep 27, 2024$297.25M-11.7%
FY2023Sep 29, 2023$336.74M+24.4%
FY2022Sep 30, 2022$270.65M-31.2%
FY2021Sep 24, 2021$393.30M+41.7%
FY2020Sep 25, 2020$277.50M+19.9%
FY2019Sep 27, 2019$231.39M-17.2%
FY2018Sep 28, 2018$279.39M+0.4%
FY2017Sep 29, 2017$278.18M+7.3%
FY2016Sep 30, 2016$259.30M+70.8%
FY2015Sep 25, 2015$151.85M-46.9%
FY2014Sep 26, 2014$286.18M+14.6%
FY2013Sep 27, 2013$249.79M+12.2%
FY2012Sep 28, 2012$222.57M-37.5%
FY2011Sep 30, 2011$356.33M+22.9%
FY2010Sep 24, 2010$289.82M+11.8%
FY2009Sep 25, 2009$259.23M+3.3%
FY2008Sep 26, 2008$250.86M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ3 2026Sep 25, 2026$73.83M-30.7%
Q3 FY2026CQ2 2026Jun 26, 2026$152.47M+148.9%
Q2 FY2026CQ1 2026Mar 27, 2026$83.44M-50.3%
Q1 FY2026CQ4 2025Dec 26, 2025$50.17M-49.8%
Q4 FY2025CQ3 2025Sep 26, 2025$106.59M-2.0%
Q3 FY2025CQ2 2025Jun 27, 2025$61.26M+348.8%
Q2 FY2025CQ1 2025Mar 28, 2025$168.00M-2.6%
Q1 FY2025CQ4 2024Dec 27, 2024$100.00M+4229.0%
Q4 FY2024CQ3 2024Sep 27, 2024$108.79M+41.6%
Q3 FY2024CQ2 2024Jun 28, 2024$13.65M-88.0%
Q2 FY2024CQ1 2024Mar 29, 2024$172.49M+77.8%
Q1 FY2024CQ4 2023Dec 29, 2023$2.31M-95.3%
Q4 FY2023CQ3 2023Sep 29, 2023$76.83M+89.2%
Q3 FY2023CQ2 2023Jun 30, 2023$113.72M-29.6%
Q2 FY2023CQ1 2023Mar 31, 2023$97.02M+88.8%
Q1 FY2023CQ4 2022Dec 30, 2022$49.18M+185.8%
Q4 FY2022CQ3 2022Sep 30, 2022$40.60M-58.5%
Q3 FY2022CQ2 2022Jul 1, 2022$161.44M+1.8%
Q2 FY2022CQ1 2022Apr 1, 2022$51.40M-26.7%
Q1 FY2022CQ4 2021Dec 31, 2021$17.21M-74.2%
Q4 FY2021CQ3 2021Sep 24, 2021$97.94M-4.2%
Q3 FY2021CQ2 2021Jun 25, 2021$158.62M+32.0%
Q2 FY2021CQ1 2021Mar 26, 2021$70.11M+48.1%
Q1 FY2021CQ4 2020Dec 25, 2020$66.63M+757.1%
Q4 FY2020CQ3 2020Sep 25, 2020$102.22M-10.2%
Q3 FY2020CQ2 2020Jun 26, 2020$120.16M+77.3%
Q2 FY2020CQ1 2020Mar 27, 2020$47.34M+317.2%
Q1 FY2020CQ4 2019Dec 27, 2019$7.77M-79.8%
Q4 FY2019CQ3 2019Sep 27, 2019$113.87M+21.4%
Q3 FY2019CQ2 2019Jun 28, 2019$67.76M-46.8%
Q2 FY2019CQ1 2019Mar 29, 2019$11.35M-81.2%
Q1 FY2019CQ4 2018Dec 28, 2018$38.41M–
Q4 FY2018CQ3 2018Sep 28, 2018$93.79M+50.1%
Q3 FY2018CQ2 2018Jun 29, 2018$127.30M+18.3%
Q2 FY2018CQ1 2018Mar 30, 2018$60.43M+0.8%
Q1 FY2018CQ4 2017Dec 29, 2017-$2.13M-104.4%
Q4 FY2017CQ3 2017Sep 29, 2017$62.48M–
Q3 FY2017CQ2 2017Jun 30, 2017$107.60M–
Q2 FY2017CQ1 2017Mar 31, 2017$59.95M–
Q1 FY2017CQ4 2016Dec 30, 2016$48.15M–

More Dolby Laboratories figures

See a number that looks wrong?